Cargando…
Emerging nanomedicines for effective breast cancer immunotherapy
Breast cancer continues to be the most frequently diagnosed malignancy among women, putting their life in jeopardy. Cancer immunotherapy is a novel approach with the ability to boost the host immune system to recognize and eradicate cancer cells with high selectivity. As a promising treatment, immun...
Autores principales: | Bahreyni, Amirhossein, Mohamud, Yasir, Luo, Honglin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7727246/ https://www.ncbi.nlm.nih.gov/pubmed/33298099 http://dx.doi.org/10.1186/s12951-020-00741-z |
Ejemplares similares
-
Mitochondria Dysfunction at the Heart of Viral Myocarditis: Mechanistic Insights and Therapeutic Implications
por: Mohamud, Yasir, et al.
Publicado: (2023) -
A combination of genetically engineered oncolytic virus and melittin-CpG for cancer viro-chemo-immunotherapy
por: Bahreyni, Amirhossein, et al.
Publicado: (2023) -
Coxsackievirus Protease 2A Targets Host Protease ATG4A to Impair Autophagy
por: Fan, Yiyun Michelle, et al.
Publicado: (2022) -
Advances in Targeting Cancer-Associated Genes by Designed siRNA in Prostate Cancer
por: Bahreyni, Amirhossein, et al.
Publicado: (2020) -
Autophagy Receptor Protein Tax1-Binding Protein 1/TRAF6-Binding Protein Is a Cellular Substrate of Enteroviral Proteinase
por: Mohamud, Yasir, et al.
Publicado: (2021)